NPC1 and acute lymphoblastic leukemia: We found that ADLL, ALL and ADL significantly improved ataxia when symptomatic Npc1−/− mice were treated acutely for 7 days; this is in agreement with observational studies in NPC1 patients (Bremova et al., 2015) treated with ADLL, using the same dosage per kg and day.